CEO Clips - Algernon Pharmaceuticals: Advancing DMT into a Phase 1 Clinical Trial
Algernon is focused on the disease areas of stroke, idiopathic pulmonary fibrosis (IPF) & chronic cough, and chronic kidney disease.
This is some text inside of a div block.